COVID-19 Patient Management in Intensive Care

Vatansever, Şule; Tekin, Esra; Gültop, Fethi; Uğurlu, Fulya; Mingir, Tarkan; Okur, Onur; Polat, Cengiz; Turgut, Namigar

doi:10.4274/eamr.galenos.2020.96977

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nebulized drugs such as salbutamol or similar types are not recommended for treating COVID-19 in non-intubated patients because they increase the risk of aerosol generation and infection spread to nearby health care professionals [42,43]. Wherever possible, metered-dose inhalers or spacers should be used.…”

Section: Specific Respiratory Physical Therapy Interventionsmentioning

confidence: 99%

The Aftermath of the COVID-19 Crisis in Saudi Arabia: Respiratory Rehabilitation Recommendations by Physical Therapists

et al. 2021

View full text Add to dashboard Cite

Since late 2019, the number of COVID-19 patients has gradually increased in certain regions as consecutive waves of infections hit countries. Whenever this wave hits the corresponding areas, the entire healthcare system must respond quickly to curb the diseases, morbidities, and mortalities in intensive care settings. The healthcare team involved in COVID-19 patients’ care must work tirelessly without having breaks. Our understanding of COVID-19 is limited as new challenges emerge with new COVID-19 variants appearing in different world regions. Though medical therapies are finding solutions to deal with the disease, there are few recommendations for respiratory rehabilitation therapies. A group of respiratory rehabilitation care professionals in Saudi Arabia and international experts have agreed with the World Health bodies such as the World Health Organization (WHO) on the treatment and rehabilitation of patients with COVID-19. Professionals participating in COVID-19 patient treatment, rehabilitation, and recovery formulated respiratory rehabilitation guidelines based on the DELPHI Method, combining scientific research and personal practical experience. As a result, it is envisaged that the number of individuals in the region suffering from respiratory ailments due to post-COVID-19 will decrease. This narrative review and clinical expertise guidelines may give physiotherapists acceptable and standard clinical guideline protocols for treating COVID-19 patients.

show abstract

Section: Specific Respiratory Physical Therapy Interventionsmentioning

confidence: 99%

The Aftermath of the COVID-19 Crisis in Saudi Arabia: Respiratory Rehabilitation Recommendations by Physical Therapists

et al. 2021

View full text Add to dashboard Cite

show abstract

“…The definition of the recovery from COVID-19 pneumoniae was based on the “SARS-CoV-2 Diagnosis and Treatment Guidelines of the Turkish Health Ministry” with minor modifications ( 12 ). The cases were grouped as mild/moderate and severe pneumonia according to the “COVID-19 Severe Pneumonia, ARDS, Sepsis and Septic Shock Management Guideline” ( 13 ). Briefly, resolutions of the clinical symptoms, normalization of blood and serum parameters, SpO2 ≥95% in normal breathing without any oxygen support, and two negative SARS-CoV-2 RT-PCR test results obtained at the interval of two consecutive days.…”

Section: Methodsmentioning

confidence: 99%

Clinical Characteristics and Outcomes of Liver Transplantation Recipients With COVID-19 Pneumonia

Kose

Toplu

Yalçınsoy

et al. 2021

Transplantation Proceedings

View full text Add to dashboard Cite

Background : We aimed to evaluate the clinical characteristics and outcomes of diagnosed with mild-severe COVID-19 pneumonia cases in liver transplantation (LT) recipients. Material and Methods : Ten LT recipients diagnosed with COVID-19 pneumonia in six-month period in our transplantation center were included. Demographic and medical data of the recipients were retrospectively collected; clinical courses, treatment responses, and outcomes were evaluated. Results : Ten LT recipients were male, at median 57 years (min-max: 36-69; IQR: 13), and had right lobe, from living-donor LT performed in median eleven months (min-max: 1-72; IQR: 12). Five patients were diagnosed as severe, and the remaining were mild/moderate pneumonia. The most frequent symptoms were fever (90%) and cough (70%). Favipiravir, enoxaparin sodium and corticosteroid were initiated at the time of the diagnosis, immunosuppressive drug doses were reduced or discontinued in three cases. Lymphopenia median: 510/ml (min-max: 90-1400; IQR: 610), increased levels of CRP median: 4.72 (min-max:0.31-23.4; IQR: 8.5) and ferritin median: 641 (min-max:40-≥1650; IQR: 1108) were frequent. Four patients required antibacterial treatments due to emerging bacterial pneumonia and/or sepsis. All patients had a hospitalization for a median of ten days. One patient with sepsis died on the 26 th day of intensive care unit (ICU) admission, and the remaining nine survived. No further complication was recorded for one-month follow-up. Conclusion : The commencing of favipiravir, enoxaparin sodium and corticosteroid treatments, close follow-up of the developing complications, temporary reduction or cessation of immunosuppression, multidisciplinary approach, early awareness of the bacterial infections and the initiation appropriate antibiotic treatments can contribute to success.

show abstract

COVID-19 Patient Management in Intensive Care

Cited by 2 publications

References 0 publications

The Aftermath of the COVID-19 Crisis in Saudi Arabia: Respiratory Rehabilitation Recommendations by Physical Therapists

The Aftermath of the COVID-19 Crisis in Saudi Arabia: Respiratory Rehabilitation Recommendations by Physical Therapists

Clinical Characteristics and Outcomes of Liver Transplantation Recipients With COVID-19 Pneumonia

Contact Info

Product

Resources

About